|
Volumn 88, Issue 10, 2010, Pages 779-790
|
Understanding diabetic teratogenesis: where are we now and where are we going?
|
Author keywords
[No Author keywords available]
|
Indexed keywords
PAIRED BOX TRANSCRIPTION FACTOR;
PAX3 PROTEIN, HUMAN;
TERATOGENIC AGENT;
ANIMAL;
APOPTOSIS;
CONGENITAL DISORDER;
EMBRYO DEVELOPMENT;
EXPERIMENTAL DIABETES MELLITUS;
FEMALE;
FETUS DISEASE;
GENE EXPRESSION REGULATION;
GENETICS;
HUMAN;
HYPERGLYCEMIA;
INSULIN DEPENDENT DIABETES MELLITUS;
METABOLISM;
MOUSE;
MOUSE MUTANT;
NEURAL TUBE DEFECT;
NON INSULIN DEPENDENT DIABETES MELLITUS;
OXIDATIVE STRESS;
PREGNANCY;
PREGNANCY DIABETES MELLITUS;
RAT;
REVIEW;
TUMOR SUPPRESSOR GENE;
ANIMALS;
APOPTOSIS;
CONGENITAL ABNORMALITIES;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETES MELLITUS, TYPE 1;
DIABETES MELLITUS, TYPE 2;
EMBRYONIC DEVELOPMENT;
FEMALE;
FETAL DISEASES;
GENE EXPRESSION REGULATION, DEVELOPMENTAL;
GENES, P53;
HUMANS;
HYPERGLYCEMIA;
MICE;
MICE, KNOCKOUT;
NEURAL TUBE DEFECTS;
OXIDATIVE STRESS;
PAIRED BOX TRANSCRIPTION FACTORS;
PREGNANCY;
PREGNANCY IN DIABETICS;
RATS;
TERATOGENS;
MLCS;
MLOWN;
|
EID: 79952198625
PISSN: None
EISSN: 15420760
Source Type: Journal
DOI: 10.1002/bdra.20704 Document Type: Review |
Times cited : (88)
|
References (0)
|